Drugs present an irresistible and lucrative target for counterfeiters. On July 16, 2003, the Food and Drug Administration launched a major initiative to more aggressively protect American consumers from counterfeit drugs.
“The sole purpose of this initiative is to develop new and innovative ways to make sure that Americans can continue to have confidence that the drugs they buy are, in fact, the real deal,” stated FDA Commissioner Mark McClellan. “There are new technologies and new opportunities for counterfeit drugs to reach Americans, but there are also new technologies and opportunities for FDA to protect the integrity of our drug supply.”
